Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

By Nelson M.R.   Reid C.M.  

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 897-903

Adis International

Access to resources Recommend Favorite

Low-Dose Aspirin Therapy for Cardiovascular Prevention: Quantification and Consequences of Poor Compliance or Discontinuation

By Herlitz Johan  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 125-141

Adis International

Access to resources Recommend Favorite

A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease

By Lamotte Mark  

PharmacoEconomics, Vol. 24, Iss. 2, 2006-01 ,pp. : 155-169

Adis International

Access to resources Recommend Favorite

Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 11, 2010-11 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Clopidogrel + aspirin beneficial for cardiovascular disease

By  

Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite